Extracellular vesicles as a drug delivery system: A systematic review of preclinical studies

Publication date

2021-08

Authors

Escudé Martinez de Castilla, Pol
Tong, Lingjun
Huang, Chenyuan
Sofias, Alexandros MariosISNI 0000000527553331
Pastorin, Giorgia
Chen, Xiaoyuan
Storm, GerritISNI 0000000042534976
Schiffelers, RaymondISNI 0000000045237985
Wang, Jiong-Wei

Editors

Advisors

Supervisors

Document Type

Article
Open Access logo

License

taverne

Abstract

During the past decades, extracellular vesicles (EVs) have emerged as an attractive drug delivery system. Here, we assess their pre-clinical applications, in the form of a systematic review. For each study published in the past decade, disease models, animal species, EV donor cell types, active pharmaceutical ingredients (APIs), EV surface modifications, API loading methods, EV size and charge, estimation of EV purity, presence of biodistribution studies and administration routes were quantitatively analyzed in a defined and reproducible way. We have interpreted the trends we observe over the past decade, to define the niches where to apply EVs for drug delivery in the future and to provide a basis for regulatory guidelines.

Keywords

Liposomes, Systematic review, Drug Delivery, Extracellular Vesicles, Preclinical animal models, Clinical trial, Taverne

Citation

Escudé Martinez de Castilla, P, Tong, L, Huang, C, Sofias, A M, Pastorin, G, Chen, X, Storm, G, Schiffelers, R M & Wang, J-W 2021, 'Extracellular vesicles as a drug delivery system : A systematic review of preclinical studies', Advanced Drug Delivery Reviews, vol. 175, 113801, pp. 1-39. https://doi.org/10.1016/j.addr.2021.05.011